Transplant recipients push back on CMS testing rule changes

CMS has revised rules for molecular diagnostic testing for organ transplant patients, limiting access and creating a barrier.

Related Keywords

United States ,American , ,American Society Of Transplant Surgeons ,American Society Of Transplantation ,Members Of Congress ,United States Today ,American Society ,Transplant Surgeons ,Medicare Administrative Contractors ,Local Coverage Determination ,Organ Transplant ,Molecular Diagnostic Testing ,Ms ,Biopsy ,Congress ,Evidence ,